Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Juli 2026 05:09 ET | Quelle: Research and Markets

ZTlido Emerges as Top Non-Opioid Pain Therapy: Market Expansion and Physician Adoption Insights

Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "ZTlido Sales Forecast, and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. Key Factors Driving ZTlido Growth ...
03. Juli 2026 04:01 ET | Quelle: Research and Markets

U.S. Radiofrequency Ablation Devices Market to Hit USD 1.02 Billion by 2033 Amid Chronic Pain Rise

Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "U.S. Radiofrequency Ablation Devices for Pain Management Market Size, Share & Trends Analysis Report by Product, End-Use, and Growth Forecasts,...
10. Juni 2026 09:00 ET | Quelle: SPR

Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief

New data just published indicated that per protocol treatment delivery of SPRINT PNS was significantly associated with achieving meaningful pain relief.
01. Juni 2026 22:58 ET | Quelle: CNI (Hong Kong) Yuanqizhi International Limited

CNI (Hong Kong) Yuanqizhi International Limited Launches Father's Day Family Wellness Package Combining In-Home Pain Management and Nutritional Solutions

CNI (Hong Kong) Yuanqizhi International Limited launches its Father's Day Family Wellness Package, blending in-home pain management and nutrition
28. Mai 2026 08:30 ET | Quelle: Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies...
25. Mai 2026 20:00 ET | Quelle: AGC Biologics, Inc.

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

AGC Biologics will provide contract development and manufacturing services for Teikoku Seiyaku’s drug candidate to treat lumbar disc herniation.
21. Mai 2026 21:05 ET | Quelle: Peak Health Research

Most Effective Magnesium Pain Cream Researched: Real Magnesium Niacinamide Relief for Peak Health & Nerve Pain Recovery

Best magnesium pain cream researched: Magnesium Niacinamide Relief supports joint, nerve, and muscle comfort with a 180-day refund.
18. Mai 2026 05:00 ET | Quelle: Research and Markets

Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth

Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Cannabis Pharmaceuticals - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Cannabis...
01. Mai 2026 12:22 ET | Quelle: Bethany Medical

Bethany Medical Expands Pain Management & Weight Loss Practice Specialties

High Point, N.C., May 01, 2026 (GLOBE NEWSWIRE) -- Bethany Medical has expanded its Pain Management & Weight Loss practice specialties with the addition of 3 new physicians and 2 Nurse...
09. April 2026 08:12 ET | Quelle: Sparian Biosciences, Inc

Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of SBS-147 Next Generation Arylepoxamide Agonist for the Treatment of Pain Funded by a $15M NIH Grant

Sparian Biosciences initiates a phase 1 clinical trial of SBS-147, its next generation arylepoxamide receptor (AEAr) agonist for acute and chronic pain.

Nächste Seite